Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Safety Study of Carfilzomib, Cyclophosphamide & Dexamethasone Prior to ASCT in Patients With Newly Diagnosed Myeloma (11-MM-01)

This study has been completed.
Onyx Pharmaceuticals
Information provided by (Responsible Party):
Academic Myeloma Consortium Identifier:
First received: August 7, 2012
Last updated: July 12, 2016
Last verified: July 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2015
  Primary Completion Date: August 2015 (Final data collection date for primary outcome measure)